Abstract

Low folate intake is associated with vascular disease. Causality has been attributed to hyperhomocysteinemia. However, human intervention trials have failed to show the benefit of homocysteine-lowering therapies. Alternatively, low folate may promote vascular disease by deregulating DNA methylation. We investigated whether folate could alter DNA methylation and atherosclerosis in ApoE null mice. Mice were fed one of six diets (n = 20 per group) for 16 weeks. Basal diets were either control (C; 4% lard) or high fat (HF; 21% lard and cholesterol, 0.15%) with different B-vitamin compositions: (1) folic acid and B-vitamin replete, (2) folic acid deficient (−F), (3) folic acid, B6 and B12 deficient (−F−B). −F diets decreased plasma (up to 85%; P < 0.05), whole blood (up to 70%; P < 0.05), and liver folate (up to 65%; P < 0.05) and hepatic SAM/SAH (up to 80%; P < 0.05). −F−B diets reduced plasma (up to 76%; P < 0.05), whole blood (up to 72%; P < 0.05), and liver B12 (up to 39%; P < 0.05) and hepatic SAM/SAH (up to 90%; P < 0.05). −F increased homocysteine 2-fold, while −F−B increased homocysteine 3.6- and 6.8-fold in the C and HF groups (P < 0.05). Plaque formation was increased 2-fold (P < 0.0001) in mice fed a HF diet. Feeding a HF–F diet increased lesion formation by 17% (P < 0.05). There was no change in 5-methyldeoxycytidine in liver or vascular tissue (aorta, periadventitial tissue and heart). These data suggest that atherogenesis is not associated with genome-wide epigenetic changes in this animal model.

Highlights

  • Suboptimal B-vitamin intake is strongly associated with predisposition to vascular disease in humans (Boushey et al 1995; Verhaar et al 2002; McNulty et al 2008)

  • Folate deficiency alone had no effect on body weight in either the C or high fat (HF) groups

  • Animals fed the −F−Bdeficient diet gained body weight at a slower rate compared with animals fed a −F diet (P

Read more

Summary

Introduction

Suboptimal B-vitamin intake is strongly associated with predisposition to vascular disease in humans (Boushey et al 1995; Verhaar et al 2002; McNulty et al 2008). Is homocysteine cardiotoxic, it causes endoplasmic reticular stress, lipid oxidation and impaired thrombolysis and vasodilation (Werstruck et al 2001; Castro et al 2006). It induces vascular smooth muscle cell (SMC) proliferation and monocyte chemotaxis (Splaver et al 2004). Subsequent meta-examination of prospective studies described a reduced risk of ischemic heart disease (11%) and stroke (19%) associated with a 25% drop in plasma homocysteine

Objectives
Methods
Results

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.